The impact of interval from surgery to chemotherapy and age in advanced-stage ovarian cancer: A GOG ancillary study.

被引:0
|
作者
Menzin, Andrew
Java, James
Lovecchio, John L.
Chi, Dennis
Tew, William P.
Bookman, Michael A.
Lichtman, Stuart M.
机构
[1] N Shore Univ Hosp, Manhasset, NY USA
[2] New York State Dept Hlth, Roswell Pk Mem Inst, Gynecol Oncol Grp, Buffalo, NY 14263 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Arizona Canc Ctr, Tucson, AZ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5057
引用
收藏
页数:1
相关论文
共 50 条
  • [21] MIRRORS STUDY: A PROSPECTIVE COHORT STUDY ASSESSING THE FEASIBILITY OF ROBOTIC INTERVAL CYTOREDUCTIVE SURGERY FOR ADVANCED-STAGE OVARIAN CANCER
    Uwins, Christina
    Read, James
    Tailor, Anil
    Crawshaw, James
    Chatterjee, Jayanta
    Ellis, Patricia
    Skene, Simon
    Michael, Agnieszka
    Butler-Manuel, Simon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A24 - A24
  • [22] Neoadjuvant chemotherapy in advanced-stage ovarian cancer - state of the art
    Margioula-Siarkou, Chrysoula
    Petousis, Stamatios
    Papanikolaou, Alexios
    Gullo, Giuseppe
    Margioula-Siarkou, Georgia
    Lagana, Antonio Simone
    Dinas, Konstantinos
    Guyon, Frederic
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (04): : 272 - 275
  • [23] Clinical experience in chemotherapy treatment for advanced-stage ovarian cancer
    Dumitru, M.
    Fagarasanu, Monica
    Cezar, Cristina
    Badescu, S.
    Tudosa, Rodica
    Soloviev, D.
    Vartej, P.
    GINECO RO, 2009, 5 (04): : 252 - 256
  • [24] Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
    Aletti, Giovanni D.
    Long, Harry J.
    Podratz, Karl C.
    Cliby, William A.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 212 - 216
  • [25] Impact of residual disease at interval debulking surgery on patterns of recurrence among patients with advanced-stage epithelial ovarian cancer
    Greer, A. C.
    Gockley, A. A.
    Manning-Geist, B. L.
    Melamed, A.
    Berkowitz, R. S.
    Horowitz, N. S.
    del Carmen, M. G.
    Clark, R. M.
    Growdon, W. B.
    Worley, M. J., Jr.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 105 - 105
  • [26] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
    Chung, Young Shin
    Kim, Yun-Ji
    Lee, Inha
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    PLOS ONE, 2017, 12 (09):
  • [27] THE IMPACT OF THE INTERVAL FROM SURGERY TO INITIATION OF CHEMOTHERAPY (ISC) ON SURVIVAL IN ADVANCED EPITHELIAL OVARIAN CANCER
    Heo, E. J.
    Lee, Y. Y.
    Kim, T. J.
    Choi, J. K.
    Kim, T. H.
    Yun, G.
    Choi, C. H.
    Lee, J. W.
    Bae, D. S.
    Kim, B. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 209 - 209
  • [28] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [29] Neoadjuvant chemotherapy versus primary surgery for advanced-stage ovarian cancer: the question remains opened
    Machiels, JP
    Berliere, M
    Mazzeo, F
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 1018 - 1019
  • [30] Impact of systematic lymphadenectomy at the time of interval debulking surgery on the survival of patients with advanced-stage epithelial ovarian carcinoma following neoadjuvant chemotherapy
    Nasioudis, Dimitrios
    Mastroyannis, Spyridon
    Latif, Nawar
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Ko, Emily
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S184 - S184